| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G5EEB3 | MEL-11; Protein MEL-11, isoform a; | mel-11; | NP_495994.1; | 1016 | c.elegen |
| G5EC49 | Cytoplasmic signalling transducer; Protein MIG-5, isoform b; | mig-5; | NP_001022317.1; | 666 | c.elegen |
| G5EBL5 | Cyclic AMP-response element binding protein 1 gamma 2; Protein CRH-1, isoform a; | crh-1; | NP_001022859.1; | 325 | c.elegen |
| G5EDQ2 | High mobility group protein I beta; Protein HMG-12; | hmg-12; hmg-I-beta; | NP_496544.1; | 315 | c.elegen |
| G5EDE5 | DRAG-1; Protein DRAG-1; | drag-1; | NP_490881.4; | 408 | c.elegen |
| G5EGA1 | Chondroitin disaccharide polymerase; Protein SQV-5, isoform b; | sqv-5; | NP_001021640.2; | 734 | c.elegen |
| G5EFZ5 | ICln1; Protein ICLN-1, isoform a; | icln-1; | NP_001021287.1; | 205 | c.elegen |
| G5EEA1 | Protein LIM-4; Putative transcription factor LIM-4; | lim-4; LIM-4; | NP_508669.1; | 355 | c.elegen |
| G5EDT6 | JKK-1; Protein JKK-1; | jkk-1; | NP_508913.1; | 435 | c.elegen |
| G5ECS8 | ADT-1; Protein ADT-1; | adt-1; | NP_510116.2; | 1461 | c.elegen |
| G5EE03 | Bladder cancer related protein; Protein Y73E7A.6; | bc10; | NP_490871.1; | 89 | c.elegen |
| G5EEK7 | Protein SHW-3; Voltage-gated K+ channel isoform 1; | shw-3; | NP_506248.2; | 479 | c.elegen |
| G5EGL7 | Kinesin-like protein; | bmk-1; | NP_001256586.1; | 958 | c.elegen |
| Q8WTK2 | Hexosaminidase; Protein HEX-4; | hex-4; | NP_740792.3; | 491 | c.elegen |
| G5EGS9 | N-acetyllactosamine synthase; Protein W02B12.11; | NULL | NP_496449.1; | 387 | c.elegen |
| Q9XUU2 | Protein SOL-2; SOL-2 protein; | sol-2; | NP_493560.1; | 436 | c.elegen |
| G5EC14 | Enhancer of polycomb-like protein; | epc-1; | NP_499642.2; | 795 | c.elegen |
| G5ECR6 | Aldose 1-epimerase; EC 5.1.3.3; Galactose mutarotase; | NULL | NP_001041189.1;NP_503684.1; | 330 | c.elegen |
| G5EDP2 | 3-keto-acyl-CoA thiolase; Protein DAF-22; | daf-22; | NP_496639.1; | 412 | c.elegen |
| G5EF90 | Protein K01D12.15; Protein K01D12.7; | NULL | NP_506102.2;NP_506106.2; | 84 | c.elegen |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |